Bekker, Linda-Gail

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., et al. (2010) · New England Journal of Medicine

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Cited by 5,096

Use of a vaginal ring containing dapivirine for HIV-1 prevention in women.

Baeten, J. M., Palanee-Phillips, T., Brown, E. R., Schwartz, K., Soto-Torres, L. E., Govender, V., Mgodi, N. M., Matovu Kiweewa, F., Nair, G., Mhlanga, F., et al. (2016) · New England Journal of Medicine

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Cited by 772

Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa

Collie, S., Champion, J., Moultrie, H., Bekker, L.-G., & Gray, G. (2022) · New England Journal of Medicine

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy

Cited by 600

Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women

Bekker, L.-G., Das, M., Abdool Karim, Q., Ahmed, K., Batting, J., Brumskine, W., Gill, K., Harkoo, I., Jaggernath, M., Kigozi, G., et al. (2024) · New England Journal of Medicine

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Cited by 523

Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism

Kim, M., Wainwright, H. C., Locketz, M., Bekker, L., Walther, G. B., Dittrich, C., Visser, A., Wang, W., Hsu, F., Wiehart, U., et al. (2010) · EMBO Molecular Medicine

Tuberculosis Research and EpidemiologyLipid metabolism and biosynthesis

Cited by 489

Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women.

Nel, A., van Niekerk, N., Kapiga, S., Bekker, L.-G., Gama, C., Gill, K., Kamali, A., Kotze, P., Louw, C., Mabude, Z., et al. (2016) · New England Journal of Medicine

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Cited by 479

Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa

Lawn, S. D., Myer, L., Bekker, L.-G., & Wood, R. (2007) · AIDS

Infectious Diseases and TuberculosisTuberculosis Research and Epidemiology

Cited by 343

HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.

Ahmed, K., Baeten, J. M., Beksinska, M., Bekker, L.-G., Bukusi, E. A., Donnell, D., Gichangi, P. B., Heller, K. B., Hofmeyr, G. J., Justman, J., et al. (2019) · The Lancet

Reproductive Health and ContraceptionHIV/AIDS Research and Interventions

Cited by 299

Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial

Jarvis, J. N., Meintjes, G., Rebe, K., Williams, G. N., Bicanic, T., Williams, A., Schutz, C., Bekker, L.-G., Wood, R., & Harrison, T. S. (2012) · AIDS

Fungal Infections and StudiesAntifungal resistance and susceptibility

Cited by 290

Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients

Bicanic, T., Muzoora, C., Brouwer, A. E., Meintjes, G., Longley, N., Taseera, K., Rebe, K., Loyse, A., Jarvis, J., Bekker, L., et al. (2009) · Clinical Infectious Diseases

Fungal Infections and StudiesAntifungal resistance and susceptibility

Cited by 227

Comprehensive clinical care for men who have sex with men: an integrated approach.

Mayer, K. H., Bekker, L.-G., Stall, R., Grulich, A. E., Colfax, G., & Lama, J. R. (2012) · The Lancet

LGBTQ Health, Identity, and PolicyHIV/AIDS Research and Interventions

Cited by 167

Tuberculosis Vaccines and Prevention of Infection

Hawn, T. R., Day, T. A., Scriba, T. J., Hatherill, M., Hanekom, W. A., Evans, T. G., Churchyard, G. J., Kublin, J. G., Bekker, L.-G., & Self, S. G. (2014) · Microbiology and Molecular Biology Reviews

Tuberculosis Research and EpidemiologyImmune responses and vaccinations

Cited by 164

Syphilis predicts HIV incidence among men and transgender women who have sex with men in a preexposure prophylaxis trial.

Solomon, M. M., Mayer, K. H., Glidden, D. V., Liu, A. Y., McMahan, V. M., Guanira, J. V., Chariyalertsak, S., Fernandez, T., Grant, R. M., Bekker, L.-G., et al. (2014) · Clinical Infectious Diseases

HIV/AIDS Research and InterventionsSyphilis Diagnosis and Treatment

Cited by 159

Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa

Hosek, S., Celum, C., Wilson, C. M., Kapogiannis, B., Delany‐Moretlwe, S., & Bekker, L. (2016) · Journal of the International AIDS Society

HIV/AIDS Research and InterventionsAdolescent Sexual and Reproductive Health

Cited by 138

Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review

Nglazi, M. D., Bekker, L.-G., Wood, R., Hussey, G. D., & Wiysonge, C. S. (2013) · BMC Infectious Diseases

Mobile Health and mHealth ApplicationsTuberculosis Research and Epidemiology

Cited by 119

Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa

Collie, S., Nayager, J., Bamford, L., Bekker, L.-G., Zylstra, M., & Gray, G. (2022) · New England Journal of Medicine

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 97

Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial.

Delany-Moretlwe, S., Lombard, C., Baron, D., Bekker, L.-G., Nkala, B., Ahmed, K., Sebe, M., Brumskine, W., Nchabeleng, M., Palanee-Philips, T., et al. (2018) · The Lancet Infectious Diseases

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Cited by 95

MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel

Cranston, R. D., Lama, J. R., Richardson, B. A., Carballo-Diéguez, A., Kunjara Na Ayudhya, R. P., Liu, K., Patterson, K. B., Leu, C.-S., Galaska, B., Jacobson, C. E., et al. (2017) · Clinical Infectious Diseases

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Cited by 60

Undetectable = Untransmittable (U = U) Messaging Increases Uptake of HIV Testing Among Men: Results from a Pilot Cluster Randomized Trial

Smith, P., Buttenheim, A., Schmucker, L., Bekker, L.-G., Thirumurthy, H., & Davey, D. L. J. (2021) · AIDS and Behavior

HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual Risk

Cited by 56

Undetectable=untransmittable (U=U) messaging increases uptake of HIV testing among men: Results from a pilot cluster randomized trial

Smith, P., Buttenheim, A., Schmucker, L., Bekker, L.-G., Thirumurthy, H., & Davey, D. L. J. (2020) · AIDS and Behavior

HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual Risk

Cited by 56

Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review protocol

Nglazi, M. D., Bekker, L.-G., Wood, R., Hussey, G. D., & Wiysonge, C. S. (2013) · Systematic Reviews

Mobile Health and mHealth ApplicationsTuberculosis Research and Epidemiology

Cited by 19

The importance of assessing and addressing mental health barriers to PrEP use during pregnancy and postpartum in sub‐Saharan Africa: state of the science and research priorities

Stanton, A. M., O'Cleirigh, C., Knight, L., Davey, D. L. J., Myer, L., Joska, J. A., Mayer, K. H., Bekker, L., & Psaros, C. (2022) · Journal of the International AIDS Society

HIV/AIDS Research and InterventionsMaternal Mental Health During Pregnancy and Postpartum

Cited by 13